Analyse Heartflow, Inc. (HTFL) — Kairos Score 63/100

À propos de Heartflow, Inc.

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.

Informations clés

🕴️ Activité des initiés (90 jours)

27 transactions — 0 achats et 16 ventes déclarés par les dirigeants de Heartflow, Inc..

🏦 Hedge Funds

15 fonds institutionnels déclarent une position sur HTFL dans leur dernière déclaration trimestrielle SEC.

📰 Actualités récentes

15 articles récents sur HTFL.

• AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion
• BCSM Exits Heartflow (HTFL) on Competitive Concerns

🧠 Ce qui fait Kairos Insider

Au-dela des donnees brutes, nous agregeons et scoring tout le signal smart money pour vous donner une vue unique.